The MDR1 (P-glycoprotein) and MRP (P-190) transporters do not play a major role in the intrinsic multiple drug resistance of Jurkat T lymphocytes

Leukemia Research

Volumn 21, Issue 11-12, 1997, Pages 1077-1086

  Martel, Julie ^a   Payet, Marcel D ^b   Dupuis, Gilles ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

ABC transporters; Cell cycle; Cytofluorimetry; Glutathione; Jurkat T cells; MDR1; MRP; Multiple drug resistance

Indexed keywords

ABC TRANSPORTER; APHIDICOLIN; COLCHICINE; CYCLOSPORIN A; CYTOSTATIC AGENT; GLYCOPROTEIN P; HYDROXYUREA; MEVINOLIN; NOCODAZOLE; RAPAMYCIN; THYMIDINE; VINBLASTINE;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; CYTOFLUOROMETRY; DRUG TRANSPORT; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; METAPHASE; MITOSIS INHIBITION; MULTIDRUG RESISTANCE; NORTHERN BLOTTING; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; T LYMPHOCYTE;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ATP-BINDING CASSETTE TRANSPORTERS; BUTHIONINE SULFOXIMINE; CELL CYCLE; CELL SURVIVAL; COLCHICINE; DRUG RESISTANCE, MULTIPLE; GLUTATHIONE; HUMANS; JURKAT CELLS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; RNA, MESSENGER; S PHASE; UP-REGULATION; VINBLASTINE;

EID: 0031438213     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00063-5     Document Type: Article

References (57)

1. Schneider, U., Schwenk, H.-U. and Bornkamm, G., Characterization of EBV-genome negative 'null' and 'T' cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. International Journal of Cancer, 1977, 19, 621.
2. Weiss, A., Imboden, J., Hardy, K., Manger, B., Terhorst, C. and Stobo, J., The role of the T3/antigen receptor complex in T-cell activation. Annual Review of Immunology, 1986, 4, 593.
3. Straus, D. B. and Weiss, A., The CD3 chains of the T cell antigen receptor associate with the ZAP-70 tyrosine kinase and are tyrosine phosphorylated after receptor stimulation. Journal of Experimental Medicine, 1993, 178, 1523.
4. Lozano, F., Places, L., Alberola-Ila, J., Milá, M., Neus, V., Barceló, J., Fabregat, V. and Vives, J., Isolation and characterisation of a CDw50 negative Jurkat T-cell line variant (PPL.1). Leukemia Research, 1993, 17, 9.
5. Weiss, A., Wiskocil, R. L. and Stobo, J. D., The role of T3 surface molecules in the activation of human T cells: a two stimulus requirement for IL-2 production reflects events occurring at a pre-translational level. Journal of Immunology, 1984, 133, 123.
6. Landegren, U., Andersson, J. and Wigzell, H., Analysis of human T lymphocyte activation in a T cell tumor model system. European Journal of Immunology, 1985, 15, 308.
7. Straus, D. B. and Weiss, A., Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell, 1992, 70, 585.
8. Weiss, A. and Littman, D. R., Signal transduction by lymphocyte antigen receptors. Cell, 1994, 76, 263.
9. Crabtree, G. R. and Clipstone, N. A., Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annual Review of Biochemistry, 1994, 63, 1045.
10. Perlmutter, R. M., Levin, S. D., Appleby, M. W., Anderson, S. J. and Alberola-Ila, J., Regulation of lymphocyte function by protein phosphorylation. Annual Review of Immunology, 1993, 11, 451.
11. Thelander, L. and Reichard, P., Reduction of ribonucleotide. Annual Review of Biochemistry, 1979, 48, 133.
12. Vincent, P. C., Young, G. A., Wass, J. and Zbroja, R. A., Differential synchronization of leukemic cells in vivo by hydroxyurea. Leukemia Research, 1982, 6, 243.
13. Alberts, A. W., Chen, J., Kuron, G., Hunt, V., Huff, J., Hoffman, C., Rothbrock, J., Lopez, M., Joshua, H., Harris, E., Patchett, A., Monaghan, R., Currie, S., Stapley, E., Albers-Schonberg, G., Hensons, O., Hirschfield, J., Hoogsteen, K., Liesch, J. and Springer, J., Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proceedings of the National Academy of Sciences USA, 1980, 77, 3957.
14. Nasheuer, H. P., Moore, A., Wahl, A. F. and Wang, T. S.-F., Cell cycle-dependent phosphorylation of human DNA polymerase α. Journal of Biological Chemistry, 1991, 266, 7893.
15. Schreiber, S. L. and Crabtree, G. R., The mechanism of action of cyclosporin A and FK506. Immunology Today, 1992, 13, 136.
16. Liu, J., FK506 and cyclosporin: molecular probes for studying intracellular signal transduction. Trends in Pharmacological Science, 1993, 14, 182.
17. Price, D. J., Grove, J. R., Calvo, V., Avruch, J. and Bierer, B. E., Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science, 1992, 257, 973.
18. Hyams, J. S. and Lloyd, C. W. (eds). Microtubules. Wiley, New York, 1993.
19. Darnell, J., Lodish, H. and Baltimore, D. Molecular Cell Biology. Scientific American Books, Freeman, New York, 1986.
20. Zieve, G. W., Turnbull, D., Mullins, J. M. and McIntosh, J. R., Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole: nocodazole accumulated mitotic cells. Experimental Cell Research, 1980, 126, 397.
21. Gottesman, M. M. and Pastan, I., Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual Review of Biochemistry, 1993, 62, 385.
22. Leveille-Webster, C. R. and Arias, I. M., The biology of the P-glycoproteins. Journal of Membrane Biology, 1995, 143, 89.
23. Cole, S. P. C., Multidrug resistance in small cell lung cancer. Canadian Journal of Physiology and Pharmacology, 1992, 70, 313.
24. Clynes, M., Cellular models for multiple drug resistance in cancer. In vitro Cellular and Developmental Biology, 1993, 29A, 171.
25. Higgins, D. F., ABC transporters: from microorganisms to man. Annual Review of Cell Biology, 1992, 8, 67.
26. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V. and Deeley, R. G., Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 1992, 258, 1650.
27. Boyum, A., Isolation of lymphocytes, granulocytes and macrophages. Scandinavian Journal of Immunology, 1976, Suppl. 5, 9.
28. Willingham, M. C., Cornwell, M. M., Cardarelli, C. O., Gottesman, M. M. and Pastan, I., Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs. Cancer Research, 1986, 46, 5941.
29. Cole, S. P. C., Chanda, E. R., Dicke, F. P., Gerlach, J. H. and Mirski, S. E. L., Non-P-glycoprotein-mediated multidrug resistance in small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II. Cancer Research, 1991, 51, 3345.
30. Skovsgaard, T., Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells. Cancer Research, 1978, 38, 1785.
31. Sambrook, J., Fritsch, E. F. and Maniatis, T. Molecular cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York, 1987.
32. Porter, K., Prescott, D. and Frye, J., Changes in surface morphology of chinese hamster ovary cells during the cell cycle. Journal of Cell Biology, 1973, 57, 815.
33. Cole, S. P. C., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M. and Deeley, R. G., Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Research, 1994, 54, 5902.
34. Zaman, G. J. R., Lankelma, J., van Tellingen, O., Beijnen, J., Dekker, H., Paulusma, C., Oude Elferink, R. P. J., Baas, F. and Borst, P., Role of glutathione in the export of compounds from cells by the multidrug-resistance-associate protein. Proceedings of the National Academy of Sciences USA, 1995, 92, 7690.
35. Meister, A., Glutathione deficiency produced by inhibition of its synthesis, and its reversal: applications in research and therapy. Pharmacology and Therapeutics, 1991, 51, 155.
36. Sinclair, W. K., Hydroxyurea: differential lethal effects on cultured mammalian cells during the cell cycle. Science, 1965, 150, 1729.
37. Maurer-Schultze, B., Siebert, M. and Bassukas, I. D., An in vivo study on the synchronizing effect of hydroxyurea. Experimental Cell Research, 1988, 174, 230.
38. Jakóbisiak, M., Bruno, S., Skierski, J. S. and Darzynkiewicz, Z., Cell cycle-specific effects of lovastatin. Proceedings of the National Academy of Sciences USA, 1991, 88, 3628.
39. Pedrali-Noy, G., Spadari, S., Miller-Faurès, A., Miller, A. O. A., Kruppa, J. and Koch, G., Synchronization of HeLa cell cultures by inhibition of DNA polymerase a with aphidicolin. Nucleic Acids Research, 1980, 8, 377.
40. Heintz, N., Sive, H. L. and Roeder, R. G., Regulation of human histone gene expression: kinetics of accumulation and changes in the rate of synthesis and in the half-lives of individual histone mRNAs during the HeLa cell cycle. Molecular and Cellular Biology, 1983, 3, 539.
41. Metcalfe, S. and Richards, F. M., Cyclosporine, FK506, and rapamycin: some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. Transplantation, 1990, 49, 798.
42. Heitman, J., Movva, N. R. and Hall, M. N., Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science, 1991, 253, 905.
43. De Brabander, M. J., Van de Veire, R. M. L., Aerts, F. E. M., Borgers, M. and Janssen, P. A. J., The effects of methyl [5-(2-thienylcarbonyl)-1H-benzimidazol-2-y1]carbamate, (R17934; NSC 238159), a new synthetic antitumoral drug interfering with microtubules, on mammalian cells cultured in vitro. Cancer Research, 1976, 36, 905.
44. Boseman Roberts, S., Segil, N. and Heintz, N., Differential phosphorylation of the transcription factor oct1 during the cell cycle. Science, 1991, 253, 1022.
45. Ueda, K., Cardarelli, C., Gottesman, M. M. and Pastan, I., Expression of a full-length cDNA for the human 'MDR1' gene confers resistance to colchicine, doxorubicin, and vinblastine. Proceedings of the National Academy of Sciences USA, 1987, 84, 3004.
46. Gros, P., Neriah, Y. B., Croop, M. M. and Housman, D. E., Isolation and expression of a complementary DNA that confers multidrug resistance. Nature, 1986, 323, 728.
47. McGrath, T. and Center, M. S., Adriamycin resistance in HL60 cells in the absence of detectable P-glycoprotein. Biochemical and Biophysical Research Communications, 1987, 145, 1171.
48. Reeve, J. G., Rabbitts, P. H. and Twentyman, P. R., Non-P-glycoprotein-mediated multidrug resistance with reduced EGF receptor expression in a human large cell lung cancer cell line. British Journal of Cancer, 1990, 61, 851.
49. Nielsen, D. and Skovsgaard, T., P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines. Biochimica et Biophysica Acta, 1992, 1139, 169.
50. Hill, B. T., Differing patterns of cross-resistance resulting from exposures to specific antitumour drugs or to radiation in vitro. Cytotechnology, 1993, 12, 265.
51. Grant, C. E., Valkimarsson, G., Kipfner, D. R., Almquist, K. C., Cole, S. P. C. and Deeley, R. G., Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Research, 1994, 54, 357.
52. Breuninger, L. M., Paul, S., Gaughan, K., Miki, T., Chan, A., Aaronson, S. A. and Kruh, G. D., Expression of multidrug resistance-associated protein in NIIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Research, 1995, 55, 5342.
53. Noguchi, K., Naito, M., Tezuka, K., Ishii, S., Seimiya, H., Sugimoto, Y., Amann, E. and Tsuruo, T., cDNA expression cloning of the 85-kDa protein overexpressed in adriamycin-resistant cells. Biochemical and Biophysical Research Communications, 1993, 192, 88.
54. Arceci, R. J., Stieglitz, K., Bras, J., Schinkel, A., Baas, F. and Croop, J., Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein. Cancer Research, 1993, 53, 310.
55. Zaman, G. J. R., Versantvoort, C. H. M., Smit, J. J. M., Eijdems, W. H. M., de Haas, M., Smith, A. J., Broxterman, H. J., Mulder, N. H., de Vries, E. G. E., Baas, F. and Borst, P., Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Research, 1993, 53, 1747.
56. Beck, J., Niethammer, D. and Gekeler, V., High mdr1-and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias. Cancer Letters, 1995, 86, 135.
57. Abbaszadegan, M. R., Futscher, B. W., Klimecki, W. T., List, A. and Dalton, W. S., Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Research, 1994, 54, 4676.